Coalition for Epidemic Preparedness Innovations & World Health Organization

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is a key funder, committing approximately $60 million to accelerate the development of Ebola Bundibugyo vaccines, and is crucial in coordinating the global response.

World Health Organization: The World Health Organization (WHO) has declared the outbreak a public health emergency and is involved in monitoring cases and coordinating the global health response.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is funding three groups, including Moderna and the University of Oxford, to accelerate the development of vaccines against the Bundibugyo strain of Ebola.

World Health Organization: The World Health Organization is leading the international response to the Ebola outbreak in the Democratic Republic of the Congo, revising its risk assessment to 'very high' nationally and launching a $518 million plan to combat the spread. Its efforts are hampered by conflict and community mistrust.

Coalition for Epidemic Preparedness Innovations: Funding vaccine development efforts, including the Oxford and Hilleman candidates. Its investment is critical for accelerating vaccine research.

World Health Organization: Leading the international response, declaring a PHEIC, recommending vaccine trials, and adding a diagnostic test to its Emergency Use Listing. Its credibility is tied to the success of the response.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) funds vaccine development and is assessing potential Ebola vaccine candidates, aiming for a rapid response.

World Health Organization: The World Health Organization>>> has declared the Ebola outbreak a public health emergency of international concern and is coordinating the international response, providing experts, supplies, and guidance, though it faces criticism for delayed detection and underestimation of the outbreak's scale.

Coalition for Epidemic Preparedness Innovations: Partner in vaccine development efforts.

World Health Organization: Leading the international response, coordinating clinical trials, and issuing warnings; faces criticism over response speed.

Coalition for Epidemic Preparedness Innovations: CEPI is listed as a partner in the urgent coordination meeting convened by Africa CDC, indicating potential involvement in the response to the Ebola outbreak.

World Health Organization: The World Health Organization has declared the Ebola outbreak a public health emergency of international concern, providing funds, dispatching teams, and coordinating global response efforts while expressing deep concern over the outbreak's scale and speed.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations is mentioned as a past collaborator with Altor BioScience, indicating Altor BioScience's involvement in epidemic preparedness.

World Health Organization: PATH is collaborating with Altor BioScience on the ROTOR project, providing global health expertise and rotavirus vaccine data for platform development, which aligns with its mission to improve global health.

Coalition for Epidemic Preparedness Innovations: CEPI is mentioned as an organization Woolhouse has advised, but no direct involvement in the catalogue.

World Health Organization: WHO's prior identification of a SARS-like coronavirus as a candidate for Disease X is validated by the research, but no direct action is taken.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations tracks emerging disease threats and funds the development of medical tools, including a Nipah vaccine.